Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors. | Academic Article |
Why?
|
| An Unusual Small Bowel Gastrointestinal Stromal Tumor Detected Via Capsule Endoscopy. | Academic Article |
Why?
|
| Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor. | Academic Article |
Why?
|
| Gastrointestinal stromal tumor (GIST) of stomach in a pediatric patient. | Academic Article |
Why?
|
| Gastrointestinal stromal tumors and leiomyosarcomas. | Academic Article |
Why?
|
| Gastrointestinal stromal tumors: insights from a new familial GIST kindred with unusual genetic and pathologic features. | Academic Article |
Why?
|
| Laparoscopic intragastric surgery for early gastric cancer and gastrointestinal stromal tumors. | Academic Article |
Why?
|
| Leiomyoma of the gastrointestinal tract with interstitial cells of Cajal: a mimic of gastrointestinal stromal tumor. | Academic Article |
Why?
|
| Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion. | Academic Article |
Why?
|
| Recurrent epimutation of SDHC in gastrointestinal stromal tumors. | Academic Article |
Why?
|
| Survival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 Patients. | Academic Article |
Why?
|
| Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. | Academic Article |
Why?
|
| Gastrointestinal stromal tumors: a spectrum of disease. | Academic Article |
Why?
|
| Gastrointestinal Stromal Tumors | Concept |
Why?
|
| Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical Trial. | Academic Article |
Why?
|